Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Study completedNCT00258700
What this trial is testing

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 478
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT01978093
What this trial is testing

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 600
Large-scale testing (Phase 3)Study completedNCT00323050
What this trial is testing

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 468
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Testing effectiveness (Phase 2)Study completedNCT00129129
What this trial is testing

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 756
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Post-approval studies (Phase 4)Study completedNCT00454987
What this trial is testing

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria MeningitidisNeisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT00289783
What this trial is testing

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,441
Large-scale testing (Phase 3)Study completedNCT00327184
What this trial is testing

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 709
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Testing effectiveness (Phase 2)Study completedNCT01090453
What this trial is testing

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 480
Large-scale testing (Phase 3)Study completedNCT00263653
What this trial is testing

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 297
Large-scale testing (Phase 3)Study completedNCT00586612
What this trial is testing

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 313
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Testing effectiveness (Phase 2)Ended earlyNCT00871741
What this trial is testing

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Who this might be right for
TetanusPoliomyelitisNeisseria Meningitidis+4 more
GlaxoSmithKline 16
Large-scale testing (Phase 3)Study completedNCT00359983
What this trial is testing

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 270
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Large-scale testing (Phase 3)Study completedNCT00345579
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,432
Next Page